Hanne Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 3.00
Lead investments 6
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 1
Stages of investment

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Therapeutics

Hanne Capital appeared to be the VC, which was created in 2017.

Besides them, we counted 1 critical employee of this fund in our database.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Hanne Capital, startups are often financed by Nest.Bio Ventures, Viventures, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are VI Ventures, Sequoia Capital China, Legend Star.

Among the various public portfolio startups of the fund, we may underline HiFiBiO Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hanne Capital:
Typical Co-investors
Hanne Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hanne Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
$9M08 Jan 2021 Dongcheng District, Beijing, China

BioNova Pharma

$25M20 Oct 2020 China, Shanghai

Celula China

$7M01 Sep 2020 -

$20M31 Aug 2020 Washington, United States


Health Care
$5M29 Jun 2020 Guangdong Province

EOC Pharma Group

Health Care
$77M02 Dec 2019 Shanghai

Health Care
$10M27 Sep 2019 Guangdong Province


$67M28 Aug 2019 Paris, Ile-de-France, France

Health Care
Medical Device
$14M21 Jan 2019 Zhejiang


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hanne Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: